Literature DB >> 16426988

Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series.

Martijn Weisfelt1, Diederik van de Beek, Lodewijk Spanjaard, Johannes B Reitsma, Jan de Gans.   

Abstract

BACKGROUND: Bacterial meningitis is a grave disease of high incidence, especially in less developed countries. Here, we describe its clinical presentation, spectrum of complications, prognostic factors, and outcome in adults with pneumococcal meningitis.
METHODS: From October, 1998, to April, 2002, we assessed 352 episodes of community-acquired pneumococcal meningitis, confirmed by culture of cerebrospinal fluid (CSF), which occurred in patients older than 16 years. Predictors for an unfavourable outcome (Glasgow outcome scale score 1-4) were identified by logistic regression with multiple imputation techniques.
FINDINGS: 245 (70%) episodes of pneumococcal meningitis were associated with an underlying disorder. Cranial CT was done for 85% of episodes and revealed underlying disorders in 17% (50/299) and meningitis-associated intracranial complications in 39% (117/299). Independent predictors for an unfavourable outcome were a low score on the Glasgow coma scale, cranial nerve palsies, a raised erythrocyte sedimentation rate, a CSF leucocyte count less than 1000 cells per mm(3), and a high CSF protein concentration on admission. Overall in-hospital mortality was 30%. Prevalence of neurological and systemic complications did not differ between patients aged younger than 60 years and those aged 60 years and older; however, systemic complications were the cause of death in 59% (32/54) of fatal episodes in patients aged 60 years and older, whereas neurological complications were the cause of death in 65% (20/31) of fatal episodes in younger patients.
INTERPRETATION: Pneumococcal meningitis is associated with high mortality and morbidity rates in adults. Whereas neurological complications are the leading cause of death in younger patients, elderly patients die predominantly from systemic complications.

Entities:  

Mesh:

Year:  2006        PMID: 16426988     DOI: 10.1016/S1474-4422(05)70288-X

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  76 in total

1.  Use of corticosteroids and other adjunct therapies for acute bacterial meningitis in adults.

Authors:  Kameshwar Prasad; Nirendra Kumar Rai; Amit Kumar
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

Review 2.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

3.  Tuberculosis and HIV are the leading causes of adult death in northwest Ethiopia: evidence from verbal autopsy data of Dabat health and demographic surveillance system, 2007-2013.

Authors:  Yigzaw Kebede; Gashaw Andargie; Abebaw Gebeyehu; Tadesse Awoke; Mezgebu Yitayal; Solomon Mekonnen; Mamo Wubshet; Temesgen Azmeraw; Yihunie Lakew; Kassahun Alemu
Journal:  Popul Health Metr       Date:  2017-07-17

4.  Genome-wide identification of Streptococcus pneumoniae genes essential for bacterial replication during experimental meningitis.

Authors:  T E Molzen; P Burghout; H J Bootsma; C T Brandt; Christa E van der Gaast-de Jongh; M J Eleveld; M M Verbeek; N Frimodt-Møller; C Østergaard; P W M Hermans
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

5.  Delayed cerebral thrombosis in bacterial meningitis: a prospective cohort study.

Authors:  Marjolein J Lucas; Matthijs C Brouwer; Diederik van de Beek
Journal:  Intensive Care Med       Date:  2012-12-18       Impact factor: 17.440

6.  Hyperglycemia in bacterial meningitis: a prospective cohort study.

Authors:  Ewout S Schut; Willeke F Westendorp; Jan de Gans; Nyika D Kruyt; Lodewijk Spanjaard; Johannes B Reitsma; Diederik van de Beek
Journal:  BMC Infect Dis       Date:  2009-05-08       Impact factor: 3.090

7.  The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion.

Authors:  Satoshi Uchiyama; Aaron F Carlin; Arya Khosravi; Shannon Weiman; Anirban Banerjee; Darin Quach; George Hightower; Tim J Mitchell; Kelly S Doran; Victor Nizet
Journal:  J Exp Med       Date:  2009-08-17       Impact factor: 14.307

8.  Macrophage migration inhibitory factor, infection, the brain, and corticosteroids.

Authors:  Madelijn Geldhoff; Barry B Mook-Kanamori; Diederik van de Beek
Journal:  Crit Care       Date:  2009-07-27       Impact factor: 9.097

9.  Diagnostic clinical and laboratory findings in response to predetermining bacterial pathogen: data from the Meningitis Registry.

Authors:  Maria Karanika; Vasiliki A Vasilopoulou; Antonios T Katsioulis; Panagiotis Papastergiou; Maria N Theodoridou; Christos S Hadjichristodoulou
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

10.  Community-acquired bacterial meningitis in alcoholic patients.

Authors:  Martijn Weisfelt; Jan de Gans; Arie van der Ende; Diederik van de Beek
Journal:  PLoS One       Date:  2010-02-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.